NSC |
Compound |
Enrichment |
Correlation |
NSC 694501 |
Null |
0.0181211508101519 |
0.15149341 |
NSC 743227 |
2-chloro-1-[4-(4-chloro-1-cyclohexyl-2,5-dioxo-2,5-dihydro-1 H-3-pyrrolylamino)phenylcarboxamido]benzene |
0.0181211508101519 |
0.42329755 |
NSC 746035 |
2-4-[(5-2,6-dimethoxy-4-[5-(3,4,5-trimethoxyphenyl)-4,5-dihydro-3-isoxazolyl]phenoxypentyl)oxy]-3-methoxyphenyl-1,2,3,4-tetrahydro-4-quinazolinone |
0.0181211508101519 |
0.27977163 |
NSC 753218 |
3-hydroxy-5,6-dihydro-6-imino-9-methoxyisoindolo-[2,1-a]quinoxaline |
0.0181211508101519 |
0.27912983 |
NSC 756233 |
GW435821X |
0.0181211508101519 |
0.42617605 |
NSC 9598 |
3-(Dimethylamino)-7-(methylimino)-3H-phenothiazine hydrochloride |
0.0181211508101519 |
0.45433122 |
NSC 721386 |
5-Fluoro-2'-deoxyuridyl 2-(1,4-naphthoquinonyl)methyl N-methyl-N-(4-chlorobutyl) phosphoramidate |
0.0187206825450445 |
-0.10433664 |
NSC 728323 |
16-[3-Methoxy-4-(2-pyrrolidine-1-yl ethoxy)benzylidene]-17-oxo-5-androsten-3a-yl acetate |
0.0187206825450445 |
0.43832493 |
NSC 132791 |
Butyric acid, 2-hydroxy-2-methyl-, 4-ester with 1,3a.beta.,4,7,7a.alpha.,11,11a,11b.alpha.-octahydro-1.alpha.,2.alpha.,4.beta.,11.beta.-tetrahydroxy-3.alpha.,8,11a.beta.-trimethyl-2H-1,11c.beta.-(epo |
0.0208632511155816 |
0.42529733 |
NSC 134459 |
Acetamide, N-(2-mercaptoethyl)-, benzoate (6CI, 7CI) |
0.0208632511155816 |
0.30549102 |